American and BRCA1 mutation carriers [1,2]. In contrast to ERpositive or HER
American and BRCA1 mutation carriers . In contrast to ERpositive or HER2overexpressing cancers, the only accessible treatment for TNBC is chemotherapy. While these cancers initially respond to neoadjuvant chemotherapy with…